Clinical trial

A Study Comparing the Closed Triple Therapy, Open Triple Therapy and a Dual Therapy for Effect on Lung Function in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

NCT02731846

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2016-06-01

PhasePHASE3

Study timeline

Study start (unknown)2016-06-01Date precision: month

Registry last updated2016-07-22

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Pulmonary Disease, Chronic Obstructiveunresolved

Interventions

Fluticasone furoate 100 mcg + Umeclidinium 62.5 mcg+Vilanterol 25 mcgDRUG

Fluticasone furoate 100 mcg + Vilanterol 25 mcgDRUG

Umeclidinium 62.5 mcgDRUG

Placebo ELLIPTA inhalerDEVICE

Albuterol/SalbutamolDRUG

Sponsors & collaborators

GlaxoSmithKlinelead sponsor

Mapped research locations

TorontoOntario, Canada2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02731846 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.